Research programme: melanocyte stimulating hormone analogues - Melacure Therapeutics

Drug Profile

Research programme: melanocyte stimulating hormone analogues - Melacure Therapeutics

Alternative Names: Alpha-melanocyte stimulating hormone analogues - Melacure Therapeutics; Alpha-MSH analogues research programme - Melacure Therapeutics; Melanocyte stimulating hormone analogues research programme - Melacure Therapeutics; MS05; MS09; MSH analogues research programme - Melacure Therapeutics; Research programme: alpha-melanocyte stimulating hormone analogues - Melacure Therapeutics; Research programme: alpha-MSH analogues - Melacure Therapeutics; Research programme: MSH analogues - Melacure Therapeutics

Latest Information Update: 18 Aug 2003

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Melacure Therapeutics (CEASED); University of Muenster; Uppsala University
  • Class
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 18 Aug 2003 Discontinued - Preclinical for Inflammation in Sweden (unspecified route)
  • 07 Nov 2002 No development reported - Preclinical for Inflammation in Sweden (unspecified route)
  • 26 Jul 2000 Preclinical development for Inflammation in Sweden (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top